study contained of the first author’s last name, publication year, country, follow-up time, number of cases and person-year, risk estimates with corresponding 95% CIs and confounding factors adjusted in multivariable analysis. We extracted the risk
Search Results
Zhen-yu Song, Qiuming Yao, Zhiyuan Zhuo, Zhe Ma, and Gang Chen
B C M Hermans, J L Derks, H J M Groen, J A Stigt, R J van Suylen, L M Hillen, E C van den Broek, E J M Speel, and A-M C Dingemans
solitary metastases, 64% of patients have N0 disease and 36% N1 disease. The prolonged survival of patients in this study with a Ki-67 PI ≤40% suggests that Ki-67 PI might be used as a prognostic factor in LCNEC patients with solitary brain metastases. A
Brijesh Krishnappa, Ravikumar Shah, Saba Samad Memon, Chakra Diwaker, Anurag R Lila, Virendra A Patil, Nalini S Shah, and Tushar R Bandgar
glucocorticoids. In IVSG, the prevalence of DI was higher in patients who did not have APH recovery. The evidence for DI as a prognostic factor in endocrine function recovery has contradictory findings. A retrospective study from an infundibulo
Shufei Zang, Lei Shi, Jinying Zhao, Min Yang, Jun Liu, and Heyuan Ding
because they are cheap and easy to use. However, no study has assessed the prognostic role of PFR in DPN patients so far. The aim of our study was to explore the diagnostic value of PFR for predicting prognosis with the optimal cut-off value in DPN
Maria Cristina De Martino, Richard A Feelders, Claudia Pivonello, Chiara Simeoli, Fortuna Papa, Annamaria Colao, Rosario Pivonello, and Leo J Hofland
further investigation as a potential prognostic factor. In the era of personalized medicine, the description of the main components of the mTOR pathway in ACCs is an important step to explore, as their presence can be considered as potential markers for
Simon Schimmack, Yongchao Yang, Klaus Felix, Markus Herbst, Yixiong Li, Miriam Schenk, Frank Bergmann, Thilo Hackert, and Oliver Strobel
A Dagohoy C Leary C Mares JE Abdalla EK Fleming JB Vauthey JN Rashid A , et al . One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States . Journal of
Sarantis Livadas, Christina Bothou, Justyna Kuliczkowska-Płaksej, Ralitsa Robeva, Andromahi Vryonidou, Jelica Bjekic Macut, Ioannis Androulakis, Milica Opalic, Zadalla Mouslech, Andrej Milewicz, Alessandra Gambineri, Dimitrios Panidis, and Djuro Macut
). However, there is controversy as to whether PCOS in itself is a risk factor for T2DM, as suggested in some studies, or whether, as proposed by others, T2DM predominantly occurs in the context of obesity ( 7 , 8 , 9 ). A recent meta-analysis of genetic
Catarina Tavares, Maria João Coelho, Catarina Eloy, Miguel Melo, Adriana Gaspar da Rocha, Ana Pestana, Rui Batista, Luciana Bueno Ferreira, Elisabete Rios, Samia Selmi-Ruby, Bruno Cavadas, Luísa Pereira, Manuel Sobrinho Simões, and Paula Soares
Endocrinology 2015 173 525 – 540 . ( https://doi.org/10.1530/EJE-15-0254 ) 10.1530/EJE-15-0254 26338373 40 Jukkola A Bloigu R Ebeling T Salmela P Blanco G. Prognostic factors in differentiated thyroid carcinomas and their
Sara Storvall, Helena Leijon, Eeva Ryhänen, Johanna Louhimo, Caj Haglund, Camilla Schalin-Jäntti, and Johanna Arola
4.10114 ) 5 Villar-del-Moral J Jiménez-García A Salvador-Egea P Martos-Martínez JM Nuño-Vázquez-Garza JM Serradilla-Martín M Gómez-Palacios A Moreno-Llorente P Ortega-Serrano J de la Quintana-Basarrate A . Prognostic factors
Cristina Lamas, Elena Navarro, Anna Casterás, Paloma Portillo, Victoria Alcázar, María Calatayud, Cristina Álvarez-Escolá, Julia Sastre, Evangelina Boix, Lluis Forga, Almudena Vicente, Josep Oriola, Jordi Mesa, and Nuria Valdés
significant prognostic factors for remission. Surgical outcome in relation to mutated exon is presented in Table 4 . Table 4 Surgical outcomes in the 57 operated patients harboring mutations in different exons of the MEN1 gene ( P < 0.001 for chi
